Hims & Hers Made a Surprising Concession to End Its GLP‑1 Beef With Novo Nordisk

Both companies’ stocks rose in the wake of the news.

BY ANNABEL BURBA, EDITORIAL ASSISTANT @ANNIEBURBA

Hims & Hers and Novo Nordisk’s very public eight-month-long feud over GLP-1 drugs just came to an end. Today, the two former rivals officially announced that they’re putting down their dukes and teaming up to sell weight-loss drugs online.

Both companies made concessions in order to broker the deal, according to Bloomberg. Novo will drop the lawsuit it filed against Hims & Hers in February and start selling its popular GLP-1 medicine brands Ozempic and Wegovy on the telehealth platform.

Hims & Hers, on the other hand, will stop advertising copycat versions of Novo drugs. It’ll continue selling Wegovy and........

© Inc.com